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ABSTRACT
Rationale Genome-wide association studies (GWASs)
have identified numerous loci associated with lower
pulmonary function. Pulmonary function is strongly related
to smoking and has also been associated with asthma
and dust endotoxin. At the individual SNP level, genome-
wide analyses of pulmonary function have not identified
appreciable evidence for gene by environment interactions.
Genetic Risk Scores (GRSs) may enhance power to identify
gene–environment interactions, but studies are few.
Methods We analysed 2844 individuals of European
ancestry with 1000 Genomes imputed GWAS data from
a case–control study of adult asthma nested within a US
agricultural cohort. Pulmonary function traits were FEV1, FVC
and FEV1/FVC. Using data from a recent large meta-analysis
of GWAS, we constructed a weighted GRS for each trait
by combining the top (p value<5×10−9) genetic variants,
after clumping based on distance (±250 kb) and linkage
disequilibrium (r2=0.5). We used linear regression, adjusting
for relevant covariates, to estimate associations of each trait
with its GRS and to assess interactions.
Results Each trait was highly significantly associated
with its GRS (all three p values<8.9×10−8). The inverse
association of the GRS with FEV1/FVC was stronger for
current smokers (pinteraction=0.017) or former smokers
(pinteraction=0.064) when compared with never smokers
and among asthmatics compared with non-asthmatics
(pinteraction=0.053). No significant interactions were observed
between any GRS and house dust endotoxin.
Conclusions Evaluation of interactions using GRSs
supports a greater impact of increased genetic susceptibility
on reduced pulmonary function in the presence of smoking
or asthma.

►► Additional supplemental
material is published online
only. To view, please visit the
journal online (http://dx.doi.
org/10.1136/thoraxjnl-2020-
215624).
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INTRODUCTION

Spirometric measures of pulmonary function, such
as FEV1, FVC and their ratio, FEV1/FVC, are robust
indices of respiratory health used in diagnosing
and monitoring various lung conditions, including
COPD. These pulmonary function metrics are
predictors of mortality, even after adjusting for
known risk factors.1–4
Pulmonary function is influenced by both genetic
and environmental factors. Genome-wide association studies (GWASs) have identified many loci associated with pulmonary function.5–9 Environmental

Key messages
What is the key question?

►► Whether the reduction in pulmonary function

associated with increasing genetic susceptibility
is enhanced or reduced by having exposures to
smoking or house dust endotoxin or by having
asthma.

What is the bottom line?

►► Smoking or asthma amplifies the reduction

in FEV1/FVC that occurs with greater genetic
susceptibility.

Why read on?

►► Using the largest genome-wide association

study meta-analysis of pulmonary function
to date, we developed a robust Genetic Risk
Score (GRS) for each pulmonary function
trait in our data. We observed a significant
interaction between the GRS for reduced FEV1/
FVC and smoking status. Our study is the
first to examine interactions between GRSs
for reduced pulmonary function and asthma
status or house dust endotoxin exposure. We
observed a marginally significant interaction
between the GRS for reduced FEV1/FVC and
asthma. The finding that the association of
genetic susceptibility with reduced pulmonary
function is strongest among current smokers
and asthmatics provides evidence that the
population with higher genetic risk for impaired
pulmonary function is more susceptible to the
deleterious effects of smoking and asthma.

exposures, most notably, cigarette smoking, also
substantially influence pulmonary function.10 11
Endotoxin, a lipopolysaccharide on the cell wall
of Gram-negative bacteria ubiquitous in the environment, is a powerful initiator of innate immune
response.12 Occupational endotoxin exposure is
associated with lower lung function.13 14 Although
endotoxin exposure in childhood might protect
against asthma development,15 in adulthood, endotoxin in house dust has been associated with lower
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pulmonary function in asthmatics.16 17 Asthma is associated with
reduced lung function in many studies.18
Considerable efforts to identify interactions between individual genetic variants and environmental exposures for many
human traits and diseases have identified few to no significant interactions.19–21 Even with large sample sizes, power is
limited to detect interactions with individual single-nucleotide
wide analyses.19 Several
polymorphisms (SNPs) in genome-
authors have highlighted the advantage of using Genetic Risk
Scores (GRSs) over individual SNPs for identifying significant
interactions.22–24 For example, a genome-wide meta-analysis
of FEV1 and FEV1/FVC by Hancock et al of nearly 50 000
individuals incorporated interaction with smoking but identified no genome-wide significant interactions despite the well-
established association of smoking with these phenotypes.20
Using the summary results from Hancock et al20 for 26 SNPs
previously identified in main effects GWAS of pulmonary function,7 Aschard et al performed single SNP-by-smoking interaction tests and found no significant interactions.24 However,
combining the effects of these individual SNPs into a GRS
identified a significant interaction between smoking status and
the GRS on FEV1/FVC.24 In a study of cotton textile workers,
Zhang et al found a significant interaction between occupational endotoxin exposure and a 10-SNP GRS for lower FEV1
for longitudinal decline in FEV1.25 We are not aware of studies
examining whether associations of GRSs with pulmonary function differ by asthma status.
Recently, a large-
scale meta-
analysis involving around 400
000 participants of European ancestry from the UK Biobank and
SpiroMeta consortium brought the number of loci for pulmonary function to nearly 300.8 This largest meta-analysis of these
outcomes to date, provides the ability to generate authoritative
risk scores for pulmonary function in individuals of European
ancestry. Shrine et al constructed a single GRS from variants
identified for any of four pulmonary function traits (FEV1, FVC,
FEV1/FVC and peak expiratory flow) weighted by the effect sizes
for FEV1/FVC but found no interaction of GRS with ever-never
smoking in relation to FEV1/FVC.8
We constructed GRSs for reduced pulmonary function based
on results from the aforementioned meta-analysis8 to investigate
whether associated genetic risk for reduced pulmonary function
is more pronounced in the presence of smoking or other exposures related to reduced pulmonary function. We constructed a
separate GRS for each of the three spirometric traits (FEV1, FVC
and FEV1/FVC) based on the meta-analysis8 and applied these
three GRSs in a case–control study of asthma in adults nested
within a US farming cohort with data on smoking and house
dust endotoxin. We examined an interaction hypothesis, namely,
whether the reduction in pulmonary function associated with
increasing GRS is enhanced or reduced by exposure to smoking
or house dust endotoxin or by having asthma.

METHODS
Study population and pulmonary function

The Agricultural Lung Health Study (ALHS) is a case–control
study of current asthma in farmers and spouses of farmers,
nested within the Agricultural Health Study.26 We enrolled 3301
participants in the ALHS from 2009 to 2013. Details regarding
the ALHS study design, including measurement of pulmonary
function, have been previously reported.16 27 28 Briefly, pulmonary function (FEV1 (in litres), FVC (in litres) and FEV1/FVC
(proportion)) was measured during home visits by trained field
technicians in accordance with American Thoracic Society
2

guidelines.16 29 Tests were graded by Dr John Hankinson; participants with quality grades of D or F were excluded from analysis.16 30

Classification of asthma

As previously described,16 27 asthma cases were identified from
the larger Agricultural Health Study cohort in three categories:
self-reported doctor-diagnosed current asthma, potential undiagnosed asthma based on the presence of current asthma symptoms
and asthma medication use in non-smokers, and overlapping
diagnoses of current asthma and either COPD or emphysema in
non-smokers. A random sample of cohort members who did not
meet any of these case definitions was selected for enrolment as
non-cases.

Endotoxin measurements

House dust samples were collected by vacuuming bedroom
floors and sleeping surfaces of participants.16 Endotoxin levels
in house dust were measured using the Limulus amebocyte
lysate assay (Lonza Walkersville, Walkersville, Maryland, USA),
as previously described.31–33 Measurements below the limit of
detection were assigned a value equal to that limit divided by the
square root of two.

Assessment of smoking

Smoking history was obtained from questionnaires. Participants
were classified as current, former or never smokers. Pack-years
were calculated as packs smoked per day times years smoked.

Genotyping

Details about the genotyping, imputation and quality control are
in the online supplemental material.

Genetic Risk Scores

Weighted GRSs were constructed using the complete summary
results from the previous meta-analysis of more than 400 000
individuals of European ancestry.8 The summary results were
pruned for linkage disequilibrium (LD) using the p value informed
clumping method in PLINK V.1.9,34 based on the LD structure in
the ALHS using a distance of ±250 kb and LD threshold of 0.5.
We used a p value threshold of 5×10―9 to maximise stringency
and for consistency with currently recommended genome-wide
significance thresholds for resequencing analyses of individuals
of European ancestry.8 35 After LD clumping, the numbers of
SNPs remaining for GRS calculation were 1123 for FEV1, 835
for FVC and 1691 for FEV1/FVC. Weighted GRSs for ALHS
participants were calculated as the weighted sum of the number
of the risk alleles using effect estimates from the UK Biobank-
SpiroMeta meta-analysis as weights.8 Further details about the
calculation of GRSs can be found in the online supplemental
material.

Statistical analyses

Using linear regression, we tested associations between each trait
(FEV1 (litres), FVC (litres) and FEV1/FVC (proportion)) and
its corresponding GRS adjusting for age, age2, height, height2,
asthma (case and non-
case), smoking status (current, former
or never), pack-years of smoking, state of residence (Iowa and
North Carolina), gender, first 10 genetic principal components and weight (kg, FVC only). Model examining associations of traits with smoking (two dummy variables for former
or current smoking vs never) included the aforementioned
covariates without pack-years or principal components. Models
Sikdar S, et al. Thorax 2021;0:1–8. doi:10.1136/thoraxjnl-2020-215624
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for association of traits with asthma were additionally adjusted
for smoking and pack-years. Endotoxin was log10-transformed
and models for association with traits were further adjusted for
season of collection of dust sample. Interactions between the
GRS and each exposure (smoking, asthma or endotoxin) were
tested by adding product terms to the aforementioned models
and adjusting for the first 10 genetic principal components.
Where we identified significant two-way interactions, we considered further three-way interaction terms with the remaining two
exposures. We considered a nominal p value cut-off of 0.05 for
statistical significance of our results. All analyses were performed
in R.36 Analyses used data release AHSREL201304.00.

RESULTS
Study participants

Among the 3301 ALHS participants, 3069 had spirometry
passing quality control and complete data on smoking, asthma
and covariates, including 2844 of European ancestry based on
principal components analysis. Among these 2844 participants,
1041 were asthma cases. Current smoking was reported by
4.3% and former smoking by 29.5% (table 1). About 52% were
farmers; the rest were spouses of farmers. House dust endotoxin
measurements were available for 2385 participants. Among
these, 177 visits were to homes where a spouse had already been
enrolled; spouses were removed, leaving 2208 participants for
analyses of endotoxin.

Association between exposures and pulmonary function

As expected, smoking status was highly significantly associated with lower FEV1 and FEV1/FVC, with larger effect estimates for current smoking than for former smoking relative
to never smoking (table 2). For FVC, inverse associations were
observed for both current and former smoking, though the
association for former smoking did not reach statistical significance (table 2). Pack-years of smoking was inversely associated
with all three pulmonary function traits: FEV1: β=―0.009 L/
pack-year, p value<2.0×10−16; FEV1/FVC: β=―0.002 L/pack-
year, p value<2.0×10−16; and FVC: β=―0.005 L/pack-year, p
value=4.4×10−12.
Asthma was highly statistically significantly associated with
lower pulmonary function for all three traits (table 2). Log10-
transformed house dust endotoxin was inversely related to all
three traits but not statistically significantly (table 2).

Genetic Risk Scores

Summary statistics of the GRSs for the three pulmonary function
traits are shown in table 3; distributions of the GRSs are shown
in online supplemental figure E1. As expected, the GRSs were
highly significantly associated with lower values for each pulmonary function trait (table 3, all p values<8.9×10−8).

Interaction between GRSs and smoking status

We observed significant interactions between the GRS for FEV1/
FVC and smoking status. The interaction effect between GRS
and smoking status shows the difference in the effects of GRS
on FEV1/FVC between smokers (current or former) and never
smokers. The inverse association between GRS and FEV1/FVC
was greater for current smokers than never smokers (table 4);
the estimated effect of GRS, per unit increase, on FEV1/FVC
in never smokers was −0.003 and that for the current smokers
was −0.012 with a difference of −0.009 (pinteraction=0.017). Even
for former smokers, the inverse association between GRS and
FEV1/FVC was higher compared with never smokers, where
Sikdar S, et al. Thorax 2021;0:1–8. doi:10.1136/thoraxjnl-2020-215624

Table 1

Characteristics of the 2844 participants

Characteristics

n (%)

Gender
 Female

1398 (49.2)

 Male

1446 (50.8)

Enrolment status
 Farmer

1491 (52.4)

 Spouse

1353 (47.6)

State
 Iowa
 North Carolina

2055 (72.3)
789 (27.7)

Current asthma status
 Case

1041 (36.6)

 Non-case

1803 (63.4)

Smoking status
 Never

1884 (66.2)

 Former

839 (29.5)

 Current

121 (4.3)

Season of endotoxin measurement (n=2208)*
 Summer

628 (28.4)

 Spring

586 (26.5)

 Fall

492 (22.3)

 Winter

502 (22.7)

FEV1
 Median (25th–75th percentiles) (L)

2.5 (2.0–3.1)

FVC
 Median (25th–75th percentiles) (L)

3.4 (2.8–4.2)

FEV1/FVC
 Median (25th–75th percentiles), proportion

0.75 (0.69–0.79)

Age
 Median (25th–75th percentiles) (years)

62.8 (54.8–71.3)

Pack-years in ever smokers
 Median (25th–75th percentiles)

9 (1.5–26.9)

Number of cigarettes per day in current smokers
 Median (25th–75th percentiles)

10 (5–20)

Endotoxin in house dust (n=2208)
 Median (25th–75th percentiles) (EU/mg)

43.5 (20.1–73.5)

*House dust endotoxin data were available for 2208 participants after removing
the 177 for whom a visit was also made to a spouse.

the estimated effect of GRS on FEV1/FVC in former smokers
was −0.006 vs −0.003 in never smokers, with a difference of
−0.003 (pnteraction=0.064). Figure 1 plots the association between
the GRS and FEV1/FVC according to smoking status and shows
that the harmful effects of smoking were larger among participants with higher GRSs. No significant interactions with the
GRS were seen with smoking for FEV1 or FVC (lowest pinterac=0.357, online supplemental table E1). We also tested for
tion
interactions between the GRS and pack-years of smoking in relation to each of the three traits but none were close to statistically
significant (FEV1: βinteraction=0.0003, pinteraction=0.406; FVC: βinter=0.0005, pinteraction=0.480; FEV1/FVC: βinteraction=−0.00002,
action
pinteraction=0.674). However, among current smokers, we observed
a significant interaction between the GRS and the number of
3
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Table 2

Association between the exposures and pulmonary function traits
FEV1 (L)

Exposures

FVC (L)

n

β (SE)

P value

1884

Referent

–

FEV1/FVC

β (SE)

P value

β (SE)

P value

Referent

–

Referent

–

−0.028* (0.024)

0.246

Smoking
 Never
 Former

839

 Current

−7

−0.108* (0.021)

121

4.2×10

−16

−0.412* (0.047)

<2.0×10

−0.280* (0.052)

9.1×10

Referent

–

Referent

–

−8

−0.023* (0.003)

4.2×10−11

−0.084* (0.008)

<2.0×10−16

Referent

–

−0.048† (0.003)

<2.0×10−16

Asthma
 No

1803

 Yes

−16

1041

−0.297† (0.019)

<2.0×10

−0.155† (0.022)

1.1×10

2208

−0.017‡ (0.015)

0.254

−0.002‡ (0.017)

0.883

−12

Endotoxin in house dust
 log10endotoxin

−0.004‡ (0.002)

0.131

*Estimates adjusted for age, age2, state, gender, height, height2 and asthma status (body weight for FVC only).
†Estimates adjusted for age, age2, state, gender, height, height2, smoking status and pack-years (body weight for FVC only).
‡Estimates adjusted for age, age2, state, gender, height, height2, asthma status, season of dust collection, smoking status, and pack-years (body weight for FVC only).

significant three-
way interaction (online supplemental table
E3 and online supplemental figure E2). The interaction effect
between GRS and former smoking (in comparison to never
smokers) for FEV1/FVC was not significantly different between
asthmatics and non-asthmatics (online supplemental table E3).

cigarettes smoked per day for FEV1/FVC (βinteraction=−0.0004,
pinteraction=0.027).
Given that there is some genetic contribution to smoking
behaviour and we identified an interaction between the GRS
and smoking status in relation to FEV1/FVC, we tested whether
its GRS was related to smoking and found no appreciable association (adjusting for age, age2, height, height2, asthma status,
state, gender and genetic principal components): former
smokers β=0.162, SE=0.096, p value=0.090; current smokers
β=−0.139, SE=0.210, p value=0.508.

Three-way interaction between smoking, gender and GRSs

Additionally, we examined whether the interaction effect
between GRS for FEV1/FVC and smoking status differed by
gender. In women, FEV1/FVC had a steeper inverse relationship with increasing genetic risk in current smokers compared
with never smokers, whereas no such difference between current
and never smokers was observed in men, yielding a significant
three-way interaction effect between GRS, gender and current
smoking (vs never smoking) (online supplemental table E4 and
figure E3). The interaction effect between GRS and former
smoking (in comparison to never smokers) was not significantly
different by gender (online supplemental table E4).

Interaction between GRSs and asthma

We observed a marginally significant interaction between the
GRS and asthma in relation to FEV1/FVC with a stronger inverse
association between the GRS and FEV1/FVC in asthmatics (estimated effect of a unit increase in GRS on FEV1/FVC=−0.006)
than non-asthmatics (−0.003) with a pinteraction=0.053 (table 5).
From figure 2, asthma had a stronger negative effect on FEV1/
FVC among participants with higher GRSs. No appreciable
interaction with asthma was seen for FEV1 or FVC (online
supplemental table E2).
Given the interaction between asthma and the GRS in relation
to FEV1/FVC, we evaluated the association between asthma and
the GRS for this trait, adjusting for age, age2, height, height2,
smoking status, pack-years, state, gender and genetic principal
components. The GRS for FEV1/FVC was not significantly
related to asthma (β=0.136, SE=0.087, p value=0.116).

Interaction between GRSs and endotoxin

We observed no significant interactions between the GRS and
endotoxin for any of the traits (table 6 and online supplemental
table E5). Because we had previously reported a stronger association between endotoxin and FEV1/FVC in asthmatics than non-
asthmatics,16 we evaluated a possible three-way interaction with
asthma but found no evidence for one (pthree-way interaction=0.667,
online supplemental table E6).

Three-way interaction between smoking, asthma and GRSs

DISCUSSION

For FEV1/FVC, we examined whether the interaction effect
between GRS and smoking status differed by asthma. In asthmatics, FEV1/FVC had steeper inverse relationship with
increased genetic risk in current smokers (when compared with
never smokers) than in non-asthmatics, yielding a statistically

Table 3

As expected, all three pulmonary function traits (FEV1, FVC
and FEV1/FVC) were significantly lower among both current
and former smokers compared with never smokers, and asthmatics had lower pulmonary function than non-
asthmatics.

Association between GRSs and pulmonary function traits
GRS

Outcome

Range

Median (25th–75th percentiles)

Mean

GRS effect estimate*

SE

P value

FEV1 (L)

17.5–29.5

21.5 (20.6–22.6)

21.8

−0.029

0.005

8.8×10−8

FVC (L)

13.1–19.8

15.8 (15.2–16.5)

15.9

−0.082

0.010

5.7×10−15

FEV1/FVC

34.2–51.5

42.1 (40.9–43.6)

42.3

−0.004

0.001

1.0×10−9

*Effect estimates provide the change in the trait (in litres for FEV1 and FVC, proportion with range 0–1 for FEV1/FVC) per one unit increase in the GRSs. Pulmonary function traits were regressed on
the GRS for that trait, with adjustment for age, age2, state, gender, height, height2, asthma status, smoking status, pack-years, first 10 principal components, and for FVC only, body weight.
GRS, Genetic Risk Score.

4
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Table 4

Interaction between smoking and GRS in relation to FEV1/FVC
FEV1/FVC

Exposure

n

Intercept*

Smoking effect†

GRS effect‡

GRS×smoking interaction: difference
in the effect of GRS per smoking
category§

1884

0.760

–

−0.003

–

Pinteraction¶

–

Smoking
 Never
 Former

839

0.738

−0.022

−0.006

−0.003

0.064

 Current

121

0.673

−0.087

−0.012

−0.009

0.017

*The intercept at each smoking category is the FEV1/FVC value for a subject in that smoking category calculated at the mean value for all continuous variables in the model (GRS, age, age2, height, height2 and 10
principal components) and at the reference category for all categorical covariates (ie, non-asthmatic, female and residing at Iowa).
†The effect of smoking is obtained by subtracting the intercept value for never smoking from the intercept value for the smoking category in question. For example, for former smokers, 0.738–0.760=−0.022 is the
difference in FEV1/FVC for a former smoker relative to a never smoker calculated at the mean value for all continuous variables (GRS, age, age2, height, height2 and 10 principal components) and at the reference
category for all categorical covariates (ie, non-asthmatic, female and residing at Iowa).
‡The effect for the GRS is the individual slope for that GRS for each exposure category and is interpretable as the difference in FEV1/FVC per unit increase in the GRS.
§The interaction effect between the GRS and smoking is the difference in the effect estimate for that GRS by smoking category and is calculated as the difference in the slope for the GRS for that smoking category
relative to never smokers. For former smokers this difference is −0.006−(−0.003)=−0.003.
¶The p value for interaction between the GRS and each smoking category.
GRS, Genetic Risk Score.

We developed a separate GRS for each of the three pulmonary
function traits in our study population using a large-scale meta-
analysis of European ancestry populations.8 These GRSs were
highly statistically significantly associated with lower values for
their corresponding pulmonary function traits. We observed a
significant interaction effect where the reduction in FEV1/FVC
with increasing GRS was more pronounced among current
smokers and former than never smokers. We also found some
evidence of interaction where the reduction in FEV1/FVC with
increasing GRS was more pronounced among asthmatics than
among non-asthmatics.
Although statistical power is reduced for higher level interactions, we evaluated possible three-way interactions in situations
where we identified significant two-way interactions. We found

08

0.7

Smoking_status

u

~

-- Current (N= 121 )

~
u.

-

Former (N=839)

-

Never (N=1884)

06

0.5

35

40

45

50

Genetic Risk Score (GRS)

Figure 1 Association between GRS and FEV1/FVC differs by smoking
status. FEV1/FVC is regressed on smoking status, GRS and their
interaction, adjusting for age, age2, height, height2, state, gender,
asthma status and 10 principal components. Shown are the estimated
FEV1/FVC values from the model against the range of GRS in our data
for the three smoking categories (never, former and current), calculated
at the mean values of all continuous variables (GRS, age, age2, height,
height2 and 10 principal components) and at the reference category
for all categorical covariates (ie, non-asthmatic, female and residing at
Iowa). The shaded areas denote 95% pointwise confidence bands. GRS,
Genetic Risk Score.
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some evidence that the interaction between GRS and current
smoking on reduced FEV1/FVC was stronger among asthmatics
than non-asthmatics and among women than men. However,
because of small numbers within these three-way cross-classified
strata, interpretation of any significant three-way interactions
requires caution.
For FEV1/FVC, we observed significant interaction between
its GRS and smoking status; for FEV1 and FVC, we did not find
interactions between their GRSs and smoking status. Results were
similar for interactions between the GRSs and asthma status:
present only for FEV1/FVC. FEV1/FVC is an index of airflow
obstruction which is a characteristic of asthma and COPD and
occurs with smoking.37 Significant interactions between GRS and
smoking or asthma for only FEV1/FVC may reflect the fact that
this parameter is independent of lung size. Genetic effects on
FEV1 and FVC, which reflect lung size, may have a predominant
impact through lung development, which takes place largely in
early life, rather than later response to environmental exposures
or diseases. We also note that Aschard et al,24 who examined
both FEV1 and FEV1/FVC, identified an interaction between
GRS and smoking predominantly for FEV1/FVC.
To our knowledge, our study is the first to examine interactions between GRS of pulmonary function traits and asthma or
house dust endotoxin exposure. Aschard et al found a significant
interaction on FEV1/FVC between an unweighted GRS based
on 26 loci and ever versus never smoking, although this finding
did not replicate in two independent datasets.24 In the larger
meta-analysis of Shrine et al, a single GRS based on 279 SNPs
weighted by the effect sizes for FEV1/FVC was constructed. That
GRS did not interact with smoking status dichotomised as ever
versus never.8 We constructed a separate GRS based on the 278
of the 279 SNPs present in our data and tested for its interaction with smoking status (current, former vs never) in relation to
FEV1/FVC. The interaction effects with smoking status were not
significant (former smokers: pinteraction=0.11, current smokers:
pinteraction=0.20). However, using the more standard approach of
creating a GRS based on clumping plus p value thresholding,
we observed a significant interaction between our 1691-SNP
GRS and smoking status in relation to FEV1/FVC. This observation also highlights the advantage of using clumping plus p
value thresholding to create a GRS over simple selection of top
SNPs as discussed by Choi et al.38 Shrine et al did not divide
ever smokers into former and current for the interactions with
GRS in their study. After several years from quitting, the decline
in pulmonary function in former smokers tends to level off, so
5
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Table 5

Interaction between asthma and GRS in relation to FEV1/FVC
FEV1/FVC

n

Intercept*

Asthma effect†

GRS effect‡

GRS×asthma interaction:
difference in the effect of GRS
per asthma category§

 No

1803

0.751

–

−0.003

–

–

 Yes

1041

0.704

−0.047

−0.006

−0.003

0.053

Exposure

Pinteraction¶

Asthma

*The intercept at each asthma category is the FEV1/FVC value for a subject in that asthma category calculated at the mean value for all continuous variables in the model (GRS, age, age2, height, height2, pack-years and
10 principal components) and at the reference category for all categorical covariates (ie, never smoker, female and residing at Iowa).
†The effect of asthma is obtained by subtracting the intercept value for non-asthmatics from the intercept value for the asthmatics; that is, 0.704–0.751=−0.047 is the difference in FEV1/FVC for an asthmatic relative to
a non-asthmatic calculated at the mean value for all continuous variables (GRS, age, age2, height, height2, pack-years and 10 principal components) and at the reference category for all categorical covariates (ie, never
smoker, female and residing at Iowa).
‡The effect for the GRS is the individual slope for GRS for each exposure category and is interpretable as the difference in FEV1/FVC per unit increase in the GRS.
§The interaction effect between the GRS and asthma is the difference in the effect estimate for the GRS by asthma category and is calculated as the difference in the slope for the GRS for asthmatics relative to non-
asthmatics; that is, −0.006−(−0.003)=−0.003.
¶The p value for interaction between the GRS and asthma.
GRS, Genetic Risk Score.

it is important to consider ever smokers in more detail. In our
study, rather than creating just one weighted GRS, we created
a separate GRS for each pulmonary function trait weighted by
the effect sizes for that trait. Our GRSs were based on the same
large comprehensive GWAS meta-analysis as Shrine et al,8 and
we found evidence of interaction with smoking considering
former and current smokers separately. The interaction was
most notable in our data for current smokers relative to never
smokers.
Our study has some limitations. Because asthma was categorised based on questionnaires, misclassification with COPD
is possible. We did not adjust for socioeconomic status (SES).
Occupation is often used to adjust for SES. Our participants
were enrolled in the parent cohort because they were either
farmers or spouses of farmers. By sharing an occupation, they
would be regarded as having similar SES. Nevertheless, when we

0.75

0

Asthma_status

~

-

No (N=1803)

-

Yes (N=1 041 )

~

u. 070

0.65

35

40

45

50

Genetic Risk Score (GRS)

Figure 2 Association between GRS and FEV1/FVC differs by asthma
status. FEV1/FVC is regressed on asthma status, GRS and their
interaction, adjusting for age, age2, height, height2, state, gender,
smoking status, pack-years, and 10 principal components. Shown are
the estimated FEV1/FVC values from the model against the range of
GRS in our data for the two asthma categories, calculated at the mean
values of all continuous variables (GRS, age, age2, height, height2,
pack-years and 10 principal components) and 0 value for all categorical
covariates (ie, never smoker, female and residing at Iowa). The shaded
areas denote 95% pointwise confidence bands. GRS, Genetic Risk Score.
6

considered education as an alternate proxy for SES, the results
did not materially change. Consistent with other genetic studies
of pulmonary function, we did not adjust for comorbidities.
However, if insufficient adjustment for SES or comorbidities can
bias estimates of interaction with the GRS, we cannot exclude
the possibility that this occurred. Because this is an agricultural population, participants potentially had higher exposure
to endotoxin than the general US population. Additionally, all
participants in this study and those in the UK Biobank and the
SpiroMeta consortium were of European ancestry. Further, variants included in the GRS have different directions of associations with the pulmonary function traits. Although we recoded
these directions to be uniform, combining the variants into a
GRS might lose some information. However, assessing interactions using GRS provides greater statistical power than using
individual variants.
In most GWAS of pulmonary function, even though multiple
correlated traits are examined simultaneously, correction for
multiple testing based on the number of traits examined is not
usually done.8 9 There are few GWASs focusing on interaction
hypotheses. We used a nominal p value of 0.05 for reporting
significant interactions. If one were to adjust interaction p values
for the three traits and three exposures considered, the p value
threshold would be 0.05/9=0.006. At this stricter correction,
none of our interaction findings would be significant. Thus,
caution is required in the interpretation of our results pending
replication in future studies.
A strength of the study is that we developed a separate GRS
for each pulmonary function trait using a meta-analysis involving
around 400 000 participants of European ancestry,8 the largest
GWAS of pulmonary function to date. This large-scale meta-
analysis enabled generation of authoritative risk scores for
pulmonary function in ALHS; we used these to investigate
whether reduced pulmonary function associated with genetic
risk is magnified in the presence of smoking or other exposures
that have been related to reduced pulmonary function.
In conclusion, we developed separate GRSs for three pulmonary function traits in our study of asthma nested within an agricultural cohort. We identified significant interactions for FEV1/
FVC between its GRS and smoking status and marginally significant interactions for FEV1/FVC between its GRS and asthma.
Our data support the use of GRS to identify environmental
interactions with genetic susceptibility. Although small numbers
induced by further stratification require caution, we saw some
evidence that, for FEV1/FVC, the interaction between its GRS
and smoking status differed by asthma and by gender. While it
Sikdar S, et al. Thorax 2021;0:1–8. doi:10.1136/thoraxjnl-2020-215624
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Table 6

Interaction between log10endotoxin and GRS in relation to FEV1/FVC
FEV1/FVC

Exposure

n

Intercept*

log10endotoxin effect†

GRS effect‡

GRS×log10endotoxin
interaction§

Pinteraction¶

2208

0.754

−0.004

−0.004

−0.001

0.248

Endotoxin
 log10endotoxin

*The intercept is the FEV1/FVC value for a subject calculated at the mean value for all continuous variables in the model (GRS, log10endotoxin, age, age2, height, height2, pack-years and 10 principal components) and at
the reference category for all categorical covariates (ie, never smoker, non-asthmatic, summer season of collection, female and residing at Iowa).
†The effect of log10endotoxin is the difference in FEV1/FVC per unit increase in log10endotoxin, calculated at the mean value for all continuous variables (GRS, age, age2, height, height2, pack-years and 10 principal
components) and at the reference category for all categorical covariates (ie, never smoker, non-asthmatic, summer season of collection, female and residing at Iowa).
‡The effect for the GRS is the slope for the GRS, which is interpretable as the difference in FEV1/FVC per unit increase in the GRS, calculated at the mean value for all continuous variables (log10endotoxin, age, age2,
height, height2, pack-years and 10 principal components) and at the reference category for all categorical covariates (ie, never smoker, non-asthmatic, summer season of collection, female and residing at Iowa).
§The interaction effect between the GRS and log10endotoxin is the difference in the effect estimate for the GRS per unit increase in log10endotoxin.
¶The p value for interaction between the GRS and log10endotoxin.
GRS, Genetic Risk Score.

has been difficult to identify appreciable evidence of gene by environment interactions in genome-wide analyses at the individual
SNP level, combining data across SNPs from large-scale GWAS
through the use of GRSs can identify such interactions. Using
the GRS approach, we find evidence that the impact of genetic
susceptibility on reduced FEV1/FVC is enhanced in the presence
of smoking or asthma. These findings provide evidence that the
population with higher genetic risk for impaired pulmonary
function is more susceptible to the deleterious effects of smoking
and asthma. Our findings might hint at potential biological
mechanisms underlying the interactions between genetic variants and exposure to smoking, or presence of asthma, in relation
to lung function. For example, significant interactions between
genetic risk for reduced pulmonary function and smoking might
suggest that some SNPs related to pulmonary function operate
by influencing pathways for response to smoking, even though
previous analyses of interaction with the individual SNPs have
not identified significant interactions. Studies incorporating
additional types of omics data, including proteomics and metabolomics, might help shed light on possible mechanisms. Future
studies assessing interaction between GRSs and factors related
to reduced pulmonary function would help to support stronger
inferences regarding potential relevance in clinical practice.
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